|Institution:||University of Basel|
|Line 1:||University of Basel|
The position is open starting from September 1st 2019 or upon agreement. Salaries are according to SNF scale and depend on experience.
Our research is dedicated to delineate mechanisms of anti-tumor immunity in tumor models and cancer patients. A major focus is the preclinical and clinical development of immunotherapeutic strategies against cancer.
Please see more details at https://www.unispital-basel.ch/ueber-uns/bereiche/medizin/kliniken-institute-abteilungen/onkologie/lehre-forschung/lab-of-cancer-immunology/ and recent publications (e.g. Claus et al, Science Transl Med 2019; Trefny et al, Clin Cancer Res 2019; Stanczak, J Clin Invest 2018; Thommen, Nat Med 2018).
Projects include the characterization of the innate and adaptive immunity in human tumors, the analysis of mechanisms of tumor-associated immune cell dysfunction including immmuno-modulatory receptors, and the development of strategies to reinvigorate immune cell function.
We offer you
Application / Contact
Applications with a full CV, short statement of research interests, publication list, and names of at least two referees should be combined to one pdf file and submitted in electronic form with the subject line "PostDoc in Cancer Immunology" to:
Prof. Dr. Alfred Zippelius
Laboratory of Cancer Immunology
Department of Biomedicine & Department of Medical Oncology
University Hospital Basel